These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 21861865)
1. Appropriate antibiotic dosing in severe sepsis and acute renal failure: factors to consider. González de Molina FJ; Ferrer R Crit Care; 2011 Aug; 15(4):175. PubMed ID: 21861865 [TBL] [Abstract][Full Text] [Related]
2. Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy. Ulldemolins M; Vaquer S; Llauradó-Serra M; Pontes C; Calvo G; Soy D; Martín-Loeches I Crit Care; 2014 Jun; 18(3):227. PubMed ID: 25042938 [TBL] [Abstract][Full Text] [Related]
3. Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Seyler L; Cotton F; Taccone FS; De Backer D; Macours P; Vincent JL; Jacobs F Crit Care; 2011; 15(3):R137. PubMed ID: 21649882 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines? Roberts JA; Roberts DM Crit Care; 2014 Jun; 18(3):156. PubMed ID: 25043141 [TBL] [Abstract][Full Text] [Related]
5. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Dellinger RP; Levy MM; Carlet JM; Bion J; Parker MM; Jaeschke R; Reinhart K; Angus DC; Brun-Buisson C; Beale R; Calandra T; Dhainaut JF; Gerlach H; Harvey M; Marini JJ; Marshall J; Ranieri M; Ramsay G; Sevransky J; Thompson BT; Townsend S; Vender JS; Zimmerman JL; Vincent JL; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Crit Care Med; 2008 Jan; 36(1):296-327. PubMed ID: 18158437 [TBL] [Abstract][Full Text] [Related]
7. Antibiotic Exposure Profiles in Trials Comparing Intensity of Continuous Renal Replacement Therapy. Jang SM; Pai MP; Shaw AR; Mueller BA Crit Care Med; 2019 Nov; 47(11):e863-e871. PubMed ID: 31397714 [TBL] [Abstract][Full Text] [Related]
8. Case-control study of drug monitoring of β-lactams in obese critically ill patients. Hites M; Taccone FS; Wolff F; Cotton F; Beumier M; De Backer D; Roisin S; Lorent S; Surin R; Seyler L; Vincent JL; Jacobs F Antimicrob Agents Chemother; 2013 Feb; 57(2):708-15. PubMed ID: 23147743 [TBL] [Abstract][Full Text] [Related]
9. Management of sepsis and septic shock in infants and children. von Rosenstiel N; von Rosenstiel I; Adam D Paediatr Drugs; 2001; 3(1):9-27. PubMed ID: 11220406 [TBL] [Abstract][Full Text] [Related]
10. To increase or decrease dosage of antimicrobials in septic patients during continuous renal replacement therapy: the eternal doubt. Wong WT; Choi G; Gomersall CD; Lipman J Curr Opin Pharmacol; 2015 Oct; 24():68-78. PubMed ID: 26667969 [TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children? Marsot A J Pharm Pharm Sci; 2020; 23():470-485. PubMed ID: 33227230 [TBL] [Abstract][Full Text] [Related]
12. [Antibiotic dosing for renal function disorders and continuous renal replacement therapy]. Michael E; Kindgen-Milles D Anaesthesist; 2015 Apr; 64(4):315-23. PubMed ID: 25812546 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics and dosing simulations of cefepime in septic shock patients receiving continuous renal replacement therapy. Carlier M; Taccone FS; Beumier M; Seyler L; Cotton F; Jacobs F; Roberts JA Int J Antimicrob Agents; 2015 Oct; 46(4):413-9. PubMed ID: 26208469 [TBL] [Abstract][Full Text] [Related]
14. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F Crit Care; 2010; 14(4):R126. PubMed ID: 20594297 [TBL] [Abstract][Full Text] [Related]
15. What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling. Delattre IK; Hites M; Laterre PF; Dugernier T; Spapen H; Wallemacq PE; Jacobs F; Taccone FS Int J Antimicrob Agents; 2020 Oct; 56(4):106113. PubMed ID: 32721604 [TBL] [Abstract][Full Text] [Related]
16. Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study. Carrié C; Petit L; d'Houdain N; Sauvage N; Cottenceau V; Lafitte M; Foumenteze C; Hisz Q; Menu D; Legeron R; Breilh D; Sztark F Int J Antimicrob Agents; 2018 Mar; 51(3):443-449. PubMed ID: 29180280 [TBL] [Abstract][Full Text] [Related]
17. Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy? De Waele JJ; Carlier M Crit Care; 2014 Jun; 18(3):158. PubMed ID: 25043643 [TBL] [Abstract][Full Text] [Related]